HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Yasutaka Hirata Ralph S. Mosca Jan M. Quaegebeur Jonathan M. Chen Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hirata, Y. Articles by Chen, J. M. Search for Related Content PubMed Articles by Hirata, Y. Articles by Chen, J. M. Related Collections Coronary disease Valve disease

J Thorac Cardiovasc Surg 2008;136:1386-1387
© 2008 The American Association for Thoracic Surgery

Brief Communication

Pediatric Application of the Thoratec CentriMag BiVAD as a Bridge to Heart Transplantation

^a Division of Cardiothoracic Surgery, Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY
^b Department of Cardiothoracic Surgery, Joan and Sanford Weill Medical College of Cornell University, New York, NY

Received for publication November 1, 2007; revisions received February 29, 2008; accepted for publication May 4, 2008.

^_* Address for reprints: Yasutaka Hirata, MD, Pediatric Cardiac Surgery, Columbia University College of Physicians and Surgeons, New York, NY. (Email: yh2240@columbia.edu).

The first 20% of the full text of this article appears below.

The Thoratec CentriMag ventricular assist device (VAD) (Thoratec Corporation Pleasanton, Calif) (Figure 1 ) is a centrifugal pump designed for extracorporeal support that operates without mechanical bearings or seals. Although extracorporeal membrane oxygenation (ECMO) provides cardiac and respiratory support in a rapid manner for the pediatric patient population, it offers only short-term support with an increase in complications beyond the second week. The CentriMag system has advantages over other systems: the pumps have a low priming volume and low requirements for heparin and hemolysis. We report three successful applications of the CentriMag BiVAD as a bridge to pediatric heart transplantation.

View larger version (126K):   Figure 1. CentriMag pump.

PATIENT 1. A 7-year-old previously healthy boy with a 10-day history of abdominal symptoms was brought to the emergency department initially stable, but his condition deteriorated and later necessitated intubation and full cardiac support; his oxygen saturation decreased to 40%. Echocardiographic analysis revealed severely decreased left ventricular function. The heart arrested in the . . . [Full Text of this Article]

This article has been cited by other articles:

				J. M. Chen, M. E. Richmond, K. Charette, H. Takayama, M. Williams, L. Gilmore, A. Garcia, and L. J. Addonizio A decade of pediatric mechanical circulatory support before and after cardiac transplantation J. Thorac. Cardiovasc. Surg., February 1, 2012; 143(2): 344 - 351. [Abstract] [Full Text] [PDF]

				R. Gerrah, K. Charette, and J. M. Chen The first successful use of the Levitronix PediMag ventricular support device as a biventricular bridge to transplant in an infant J. Thorac. Cardiovasc. Surg., November 1, 2011; 142(5): 1282 - 1283. [Full Text] [PDF]

				H. Takayama, J. M. Chen, U. P. Jorde, and Y. Naka Implantation technique of the CentriMag biventricular assist device allowing ambulatory rehabilitation Interact CardioVasc Thorac Surg, February 1, 2011; 12(2): 110 - 111. [Abstract] [Full Text] [PDF]